A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jesús Medina, PhD
AstraZeneca
Study Director - John Wilding, MBChB, DM
Universtiy of Liverpool, University Hospital, Aintree, Longmoor Lane, Liverpool, L9 7AL, UK
Principal Investigator - Susan Beatty, MSc
Clinical Practice Research Datalink
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
132 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Forfar, Angus, United Kingdom
- Research Site
Yate, Avon, United Kingdom
- Research Site
Bracknell, Berkshire, United Kingdom
- Research Site
Reading, Berkshire, United Kingdom
- Research Site
Wokingham, Berkshire, United Kingdom
- Research Site, Alum Rock
Birmingham, Birmingham, United Kingdom
- Research Site
Maesteg, Bridgend, United Kingdom
- Research Site
Chew Stoke, Bristol, United Kingdom
- Research Site
Yate, Bristol, United Kingdom
- Research Site
Iver, Bucks, United Kingdom
- Research Site
Blackwood, Caerphilly, United Kingdom
- Research Site
Hengoed, Caerphilly, United Kingdom
- Research Site
Greenisland, Carrickfergus, United Kingdom
- Research Site
Whitehead, Carrickfergus, United Kingdom
- Research Site
Macclesfield, Cheshire, United Kingdom
- Research Site
Crook, County Durham, United Kingdom
- Research Site
Denbigh, Denbighshire, United Kingdom
- Research Site
Exeter, Devon, United Kingdom
- Research Site
Hull, East Yorkshire, United Kingdom
- Research Site
Romford, Essex, United Kingdom
- Research Site
Pinhoe, Exeter, United Kingdom
- Research Site
Cheltenham, Gloucestershire, United Kingdom
- Research Site
Trafford, Greater Manchester, United Kingdom
- Research Site
Worsley, Greater Manchester, United Kingdom
- Research Site
Alton, Hampshire, United Kingdom
- Research Site
Farnborough, Hampshire, United Kingdom
- Research Site
Gosport, Hampshire, United Kingdom
- Research Site
Havant, Hampshire, United Kingdom
- Research Site
Romsey, Hampshire, United Kingdom
- Research Site
Southampton, Hampshire, United Kingdom
- Research Site
Waterlooville, Hampshire, United Kingdom
- Research Site
Winchester, Hampshire, United Kingdom
- Research Site
Southampton, Hants, United Kingdom
- Research Site
Leominster, Herefordshire, United Kingdom
- Research Site
Fortrose, Highland, United Kingdom
- Research Site
Beckenham, Kent, United Kingdom
- Research Site
Canterbury, Kent, United Kingdom
- Research Site
Faversham, Kent, United Kingdom
- Research Site
Gravesend, Kent, United Kingdom
- Research Site
Rainham, Kent, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Aug 2016
- Primary completion
- 12 Dec 2025
- Completion
- 12 Dec 2025
- Last update posted
- 20 Feb 2026
- Registered enrollment
- 632
- Registry id
- NCT02616666
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.